Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells. - Volinia S; Bertagnolo V; Grassilli S; Brugnoli F; Manfrini M; Galasso M; Scatena C; Mazzanti CM; Lessi F; Naccarato G; Caligo A; Bianchini E; et al. (Oncotarget, 2018)